Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay 100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization
COVAXINÒ is the one of the first COVID-19 vaccines in the world to generate data in 2-18 year age group. Phase II/III, Open-Label, Multi-centre Study was conducted to evaluate the Safety, Reactogenicity, and Immunogenicity of the Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN®) in healthy children
The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat Biotech
According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation
WHO chief scientist Soumya Swaminathan has said, citing sero-survey results and huge learning loss over past 18 months that Tamil Nadu should consider reopening schools for all classes,. On Sunday in an event, Soumya said one of the main findings of ICMR’s fourth sero prevalence study conducted in June
With specialised bio safety containment facilities in Hyderabad, Malur, Ankleshwar, and Pune, Bharat Biotech steadily moves towards its aim of ~ 1 billion doses of annualised capacity. Product manufactured from Ankleshwar facilities will be available for supplies starting September 2021 Bharat Biotech, a global leader in
India has done better than any country in the world as regards to affordability and the reach to the people of COVID-19 vaccines, Bharat Biotech Chairman and Managing Director Krishna Ella said on Sunday. Highlighting the enormity of the task of vaccination, Ella said, “When you
Health Minister Mansukh Mandaviya declared through a tweet that India has given approval to Johnson & Johnson's single-dose COVID-19 vaccine for emergency use. Meanwhile the company said it was too early to predict by when delivery is possible. Earlier on the large medical conglomerate had applied
Prequalification will fast-track procurement and global access of ROTAVAC 5D® The only rotavirus vaccine in the world to be delivered in a 0.5 ml dose volume Bharat Biotech today announced that the World Health Organization (WHO) has awarded prequalification to its rotavirus vaccine, ROTAVAC 5D®.
Dr. Krishna Ella, CMD, Bharat Biotech appreciated the efforts of Doctors’ and support staff during an event to commemorate World Hepatitis Day at KIMS Hospitals Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech today said that Science and Innovation in India is on par with
